HERON THERAPEUTICS, INC. /DE/ — Form 8-K
Filed August 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Heron Therapeutics amended its Tax Benefit Preservation Plan (a shareholder rights plan) on August 13, 2026, extending the Final Expiration Date from August 14, 2026 to August 14, 2029. The amendment was executed by CEO Craig Collard and Computershare Trust Company, N.A. as Rights Agent. The Plan remains otherwise unchanged and redeemable by the company.
Why this rating
Routine administrative extension of anti-takeover plan; no financial impact, no operational change, standard governance maintenance for small-cap company.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.